From January 1, 2024 to April 25, 2024, the company has repurchased 986,928 shares, representing 1.56% for $15.64 million. With this, the company has completed the repurchase of 7,807,887 shares, representing 11.78% for $100 million under the buyback announced on November 9, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.5 USD | 0.00% |
|
+2.23% | +2.87% |
Jul. 02 | Innoviva, Inc.'s Subsidiary Innoviva Specialty Therapeutics, Inc. Appoints Patricia Drake as Chief Commercial Officer | CI |
Jun. 18 | Cantor Fitzgerald Initiates Innoviva at Overweight Rating | MT |
![Consensus](/images/consensus_flch.gif)
1st Jan change | Capi. | |
---|---|---|
+2.87% | 1.03B | |
+55.55% | 823B | |
+42.31% | 641B | |
-6.83% | 352B | |
+17.15% | 324B | |
+7.09% | 301B | |
+14.02% | 241B | |
+1.64% | 223B | |
+13.66% | 218B | |
+7.87% | 167B |
- Stock Market
- Equities
- INVA Stock
- News Innoviva, Inc.
- Tranche Update on Innoviva, Inc.'s Equity Buyback Plan announced on November 9, 2022.